Freeman Ellen W, Sammel Mary D, Lin Hui, Nelson Deborah B
Department of Obstetrics/Gynecology, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA.
Arch Gen Psychiatry. 2006 Apr;63(4):375-82. doi: 10.1001/archpsyc.63.4.375.
Whether depressed mood reported in the transition to menopause by women with no history of depression is associated with menopausal status and changes in reproductive hormones is controversial and lacks scientific information.
To identify new onset of depressive symptoms and diagnosed depressive disorders in the menopausal transition and to determine the associations of menopausal status, reproductive hormones, and other risk factors with these cases.
A within-woman, longitudinal (8-year) study to identify risk factors of depressed mood.
A subset of a randomly identified, population-based cohort.
Premenopausal women with no history of depression at cohort enrollment.
The Center for Epidemiological Studies of Depression scale (CES-D) was used to assess depressive symptoms, and the Primary Care Evaluation of Mental Disorders (PRIME-MD) was used to identify clinical diagnoses of depressive disorders.
High CES-D scores (> or=16) were more than 4 times more likely to occur during a woman's menopausal transition compared with when she was premenopausal (odds ratio, 4.29; 95% confidence interval, 2.39-7.72; P<.001). Within-woman change in menopausal status, increased levels of follicle-stimulating hormone and luteinizing hormone, and increased variability of estradiol, follicle-stimulating hormone, and luteinizing hormone around the woman's own mean levels were each significantly associated with high CES-D scores after adjusting for smoking, body mass index, premenstrual syndrome, hot flashes, poor sleep, health status, employment, and marital status. A diagnosis of depressive disorder was 2(1/2) times more likely to occur in the menopausal transition compared with when the woman was premenopausal (odds ratio, 2.50; 95% confidence interval, 1.25-5.02; P=.01); the hormone measures were also significantly associated with this outcome.
Transition to menopause and its changing hormonal milieu are strongly associated with new onset of depressed mood among women with no history of depression.
既往无抑郁病史的女性在绝经过渡期间报告的情绪低落是否与绝经状态及生殖激素变化相关存在争议且缺乏科学依据。
识别绝经过渡期间新发的抑郁症状和已诊断的抑郁障碍,并确定绝经状态、生殖激素及其他危险因素与这些情况的关联。
一项针对女性的纵向(8年)研究,以识别情绪低落的危险因素。
基于人群的随机识别队列的一个子集。
队列入组时无抑郁病史的绝经前女性。
采用流行病学研究中心抑郁量表(CES-D)评估抑郁症状,采用精神障碍初级保健评估(PRIME-MD)识别抑郁障碍的临床诊断。
与绝经前相比,女性在绝经过渡期间CES-D高分(≥16分)出现的可能性高出4倍多(比值比,4.29;95%置信区间,2.39 - 7.72;P <.001)。在调整吸烟、体重指数、经前综合征、潮热、睡眠不佳、健康状况、就业和婚姻状况后,女性绝经状态的变化、促卵泡生成素和促黄体生成素水平升高,以及雌二醇、促卵泡生成素和促黄体生成素围绕女性自身平均水平的变异性增加,均与CES-D高分显著相关。与绝经前相比,绝经过渡期间诊断为抑郁障碍的可能性高出2.5倍(比值比,2.50;95%置信区间,1.25 - 5.02;P =.01);激素指标也与这一结果显著相关。
向绝经的过渡及其不断变化的激素环境与既往无抑郁病史的女性新发情绪低落密切相关。